AIA Private Health vs Health Positive: Pharmac vs non-Pharmac drug cover
NZ's Pharmac funds a defined list of medicines. A medicine that is not on the Schedule, or is funded only for other conditions (Keytruda is funded for some cancers and not others), is not publicly funded for you. Health insurance can fill that gap — but every insurer handles it differently. This page summarises each NZ insurer's non-Pharmac rules verbatim from their policy wordings.
AIA AIA Private Health
Wording effective 2026-05-16
Non-Pharmac subsidised drugs are excluded generally: 'Drugs required for your particular treatment that are not subsidised by Pharmac, except for the drugs required for the chemotherapy benefit under Cancer Care in AIA Private Health Cover.' Under Cancer Care, the policy covers 'the cost of Pharmac and non-Pharmac subsidised MedSafe indicated cancer chemotherapy and immunotherapy drugs, subject to AIA criteria.' No specific mention of Keytruda by name.
UniMed Health Positive
Wording effective 2025-08-01
User part charges for prescription items on the New Zealand Pharmaceutical Schedule and prescribed by a Registered Medical Practitioner (including psychiatric medications) are covered up to $300 per annum with a 3-month no-claiming period. Non-Pharmac Subsidised Pharmaceuticals prescribed by a Registered Medical Practitioner in General Practice which have been approved by Medsafe and are not fully or partially subsidised by Pharmac through the New Zealand Pharmaceutical Schedule are also covered up to $300 per annum with a 3-month no-claiming period.
Source: https://www.unimed.co.nz/assets/PlansAndDocs/Health-Plans/Health_Positive_Plan.pdf